These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1635059)

  • 1. Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents.
    Das J; Floyd DM; Kimball SD; Duff KJ; Lago MW; Krapcho J; White RE; Ridgewell RE; Obermeier MT; Moreland S
    J Med Chem; 1992 Jul; 35(14):2610-7. PubMed ID: 1635059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
    J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones.
    Das J; Floyd DM; Kimball SD; Duff KJ; Vu TC; Lago MW; Moquin RV; Lee VG; Gougoutas JZ; Malley MF
    J Med Chem; 1992 Feb; 35(4):773-80. PubMed ID: 1542103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.
    Floyd DM; Kimball SD; Krapcho J; Das J; Turk CF; Moquin RV; Lago MW; Duff KJ; Lee VG; White RE
    J Med Chem; 1992 Feb; 35(4):756-72. PubMed ID: 1542102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.
    Kimball SD; Hunt JT; Barrish JC; Das J; Floyd DM; Lago MW; Lee VG; Spergel SH; Moreland S; Hedberg SA
    Bioorg Med Chem; 1993 Oct; 1(4):285-307. PubMed ID: 8081860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects.
    Atwal KS; O'Reilly BC; Ruby EP; Turk CF; Aberg G; Asaad MM; Bergey JL; Moreland S; Powell JR
    J Med Chem; 1987 Apr; 30(4):627-35. PubMed ID: 2435902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally constrained calcium channel blockers: novel mimics of 1-benzazepin-2-ones.
    Barrish JC; Spergel SH; Moreland S; Grover G; Hedberg SA; Pudzianowski AT; Gougoutas JZ; Malley MF
    Bioorg Med Chem; 1993 Oct; 1(4):309-25. PubMed ID: 8081861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.
    Kimball SD; Floyd DM; Das J; Hunt JT; Krapcho J; Rovnyak G; Duff KJ; Lee VG; Moquin RV; Turk CF
    J Med Chem; 1992 Feb; 35(4):780-93. PubMed ID: 1311765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of 1-isopropyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel antihypertensive agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Chem Pharm Bull (Tokyo); 2011; 59(8):1029-37. PubMed ID: 21804249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
    Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.
    Atwal KS; Swanson BN; Unger SE; Floyd DM; Moreland S; Hedberg A; O'Reilly BC
    J Med Chem; 1991 Feb; 34(2):806-11. PubMed ID: 1995904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiophene systems. 14. Synthesis and antihypertensive activity of novel 7-(cyclic amido)-6-hydroxythieno[3,2-b]pyrans and related compounds as new potassium channel activators.
    Sanfilippo PJ; McNally JJ; Press JB; Fitzpatrick LJ; Urbanski MJ; Katz LB; Giardino E; Falotico R; Salata J; Moore JB
    J Med Chem; 1992 Nov; 35(23):4425-33. PubMed ID: 1447742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 2-amino-1,4-dihydropyridine calcium antagonists. I. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having nitroxy-alkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Kita Z; Yoshiya H; Nishino S; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):788-96. PubMed ID: 7553966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diethyl-4,4'-dihydroxy-8,3'-neolign-7,7'-dien-9,9'-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels.
    Singh A; Kumar BS; Alam S; Iqbal H; Shafiq M; Khan F; Negi AS; Hanif K; Chanda D
    Eur J Pharmacol; 2017 Mar; 799():84-93. PubMed ID: 28159537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.